Global Commercial Pharmaceutical Analytics Market Therapeutics and Pipeline Review H2 2027


Global Commercial Pharmaceutical Analytics Market
Introduction
Pharmaceuticals analytics refers to the use of analytical software to analyze and manage biomedical and biological data from life science industries like hospitals, pharmaceutical companies, and laboratories.
The global commercial pharmaceutical analytics market was valued at USD 1.0 billion in 2015, and is expected grow at a CAGR of around 20% during the forecast period. This rapid growth is majorly attributed to growing adoption of new technologies & analytical tools in process streamlining, as well as the growing pharmaceutical industry, especially in developing nations. On the other hand, lack of skilled professionals and high software cost are major obstacles restraining the market growth.
The market is mainly segmented on the basis of type, deployment method, applications, and regions. Market segmentation by types include sub-segments namely, descriptive analytics, predictive analytics and prescriptive analytics. The descriptive analytics sub-segment, valued at USD 817.9 million, held more than 75% market share in 2015.
Market categorization based on deployment methods includes on-premise deployment, and web-based/cloud based deployment. The market has also been segmented based on applications into research & development, marketing & sales, supply chain optimization, internal reporting, and other applications.
North America held the largest market share of around 49% within the global commercial pharmaceutical analytics market, in 2015. Europe market, valued at USD 282.7 million, held the second largest market share in 2015. 
               
Click here for sample report @http://www.wiseguyreports.com/sample-request/885797-global-commercial-pharmaceutical-analytics-market-estimation-forecast-to-2027
Key Players
The leading players of the global commercial pharmaceutical analytics market are Tata Consultancy Services Limited (India), ORACLE (U.S.), Northwest Analytics, Inc. (U.S.), Wipro Limited (India), Microsoft (U.S.), Allscripts (U.S.), Cerner Corporation (U.S.), and Fuzzy Logix, Inc. (U.S.).

Study Objectives
• To provide insights about factors influencing and affecting the market growth
• To provide historical and forecast revenue of the market segments and sub-segments with respect to regional markets and their key countries
• To provide historical and forecast revenue of the market segments based on types, applications, and method of deployment
• To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market
Target Audience
•    Medical Devices & Pharmaceutical companies
•    Software development & IT firms
•    Hospitals & Clinics
•    Potential Investors
•    Raw Material Suppliers
•    Key executive (CEO and COO) and strategy growth manager
Key Findings
• On the basis of type, predictive analytics is the fastest growing segment and is expected grow at 20.4% CAGR during the forecast period to reach USD 1.5 billion by 2027
• With revenue of USD 630.0 million, the on premise deployment has held the largest market share of around 60% within the commercial pharmaceutical analytics market, in 2015
• Marketing & sales is the fastest growing application segment, and is anticipated to grow at a CAGR of 20.5% between 2016 and 2027
• Asia-Pacific region is estimated to achieve the fastest growth of 20.8% CAGR during the forecast period on account of high adoption rate in the following decade

The report also covers country level analysis:
• North America
o US
o Canada
• Europe
o Western Europe
o Germany
o France
o U.K.
o Italy
Table of Contents

1 Introduction 9
1.1 Definition 9
1.2 Scope of Study 9
1.3 Research Objective 10
1.4 Assumptions & Limitations 10
1.5 Market Structure: 11
2 Research Methodology 12
2.1 Research Process: 12
2.2 Primary Research 12
2.3 Secondary Research: 13
3 Market Dynamics 14
Continued
For Detailed Reading Please visit @https://www.wiseguyreports.com/reports/885797-global-commercial-pharmaceutical-analytics-market-estimation-forecast-to-2027
About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Contact Us:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
www.wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)

Comments

Post a Comment

Popular posts from this blog

Hypotension Treatment Market 2018 – 2023 Projected to Grow Radiantly by Top Players Revenue and Growth Rate

Market Overview: Hypotension refers to very low blood pressure and affects people across all age groups. Blood pressure is the force exerted by human blood against the artery walls, while blood is pumped out by the heart. Hypotension is normally characterized by a diastolic pressure that is lower than 60mm Hg. A systolic pressure lower than 90 mm Hg is also typically symptomatic of hypotension. The global hypotension market is propelled by hypotension incidences, diabetes, cardiovascular disorders, and other health issues. When patients suffer from low blood pressure or hypotension, they may feel dizziness while standing up after sitting for long periods of time. This is why, many of them are advised to not rise suddenly and take support/more time to stand up without any discomfort. Hypotension can also result from dehydration, nervous disorders, and endocrine issues. The geriatric population is quite susceptible to suffering from low blood pressure, boosting the rates of hosp...
Read more

Hemostasis and Tissue Sealing Agents Market Forecasts by Industry Drivers, Regions Till 2030

  Market Highlights The global  hemostasis and tissue sealing agents market size  is projected to grow at a CAGR of 8.6% over the forecast period. There has been increasing demand for such products as it reduces complication during surgical procedures. Moreover, large number of surgical procedures across the globe are impacting the growth of the market positively. Increasing numbers of surgery procedures worldwide is one of another reason for driving the growth of the hemostasis and tissue sealing agents market.  Surgeries are performed by making cut on the body which leads to the wound formation. Hemostasis and tissue sealing agents products are used in external surgical processes for reducing bleeding. For example, they are used in neurosurgical procedures, cardiac surgery, bariatric surgery, leg surgery, cesarean and orthopedic surgery. Hemostasis and tissue sealing agents products, are frequently used to reduce complexity and reduce recovery time after surgery. T...
Read more

Stem Cell Manufacturing Market Professional Overview 2022-2030 with Major Vendors Size, Shares and Worldwide Demand

  Stem Cell Manufacturing Market - Highlights The Stem Cell Manufacturing Industry is expected to have accounted for the market value of USD 10.8 billion in 2022 and is projected to grow at a Stem Cell Manufacturing Market CAGR of 6.6% over the assessment period. Stem cell manufacturing is a process in which cells from the bone marrow or peripheral blood cells are isolated and cultured in a culture dish containing nutrient media. Rising stem cell related transplants, increasing number of clinical trials for stem cell therapies and growing stem cell research is anticipated to boost the growth of the market during the assessment period. According to a report published by Lozier Institute in November 2022, there are nearly 3,500 ongoing or completed clinical trials (in patients) using adult stem cells, as listed in the National Institutes of Health/FDA-approved database. On the other hand, high costs associated with stem cell research and stringent govern...
Read more